A novel LASSO‐derived prognostic model predicting survival for non‐small cell lung cancer patients with M1a diseases
Abstract Introduction The current American Joint Committee on Cancer (AJCC) M1a staging of non‐small cell lung cancer (NSCLC) encompasses a wide disease spectrum, showing diverse prognosis. Methods Patients who diagnosed in an earlier period formed the training cohort, and those who diagnosed therea...
Main Authors: | Hongchao Chen, Chen Huang, Huiqing Ge, Qianshun Chen, Jing Chen, Yuqiang Li, Haiyong Chen, Shiyin Luo, Lilan Zhao, Xunyu Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-03-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.4560 |
Similar Items
-
Construction and Validation of A Nomogram Prognostic Model for Patients with Lung Adenocarcinoma
by: LUO Wenqing, et al.
Published: (2022-03-01) -
Construction and validation of prognostic nomograms for elderly patients with metastatic non‐small cell lung cancer
by: Haishuang Sun, et al.
Published: (2022-05-01) -
Development and validation of prognostic models for small cell lung cancer patients with liver metastasis: a SEER population-based study
by: Qiaofeng Li, et al.
Published: (2024-01-01) -
Individualized prediction of survival benefit from postoperative radiotherapy for patients with malignant pleural mesothelioma
by: Yang Wo, et al.
Published: (2023-06-01) -
Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysis
by: Tao Ge, et al.
Published: (2022-11-01)